RxDoctor Payments DataLook up a doctor →

Carlos Ramirez Mejia, MD

Sleep Medicine · Miami, FLNPI 1053375360

Payments from drug & device makers

$24,608in general payments, 2019–2025

Across 1,040 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • UCB, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • Pfizer$1K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)213$4,747
UCB, Inc.49$1,902
Teva Pharmaceuticals USA, Inc.48$1,587
Lilly USA, LLC50$1,078
Amgen39$1,070
Pfizer56$1,020
AstraZeneca(2 entities)42$878
Novartis36$786
Lundbeck LLC34$778
Neurelis, Inc.36$713
Scilex Pharmaceuticals Inc.33$700
Eisai Inc.16$628
Acadia Pharmaceuticals Inc27$525
Biogen24$513
SK Life Science, Inc.16$458
Neurocrine Biosciences, Inc.29$435
MDD US Operations, LLC6$417
Sanofi23$391
Harmony Biosciences LLC8$390
Kyowa Kirin, Inc.12$356
Otsuka America Pharmaceutical, Inc.19$350
Sunovion Pharmaceuticals Inc.18$346
Merz Pharmaceuticals, LLC12$286
Biohaven Pharmaceutical Holding Company Ltd.7$265
Supernus Pharmaceuticals, Inc.17$260
Boston Scientific5$245
Alnylam Pharmaceuticals Inc.8$194
Acorda Therapeutics, Inc11$193
Azurity Pharmaceuticals, Inc.8$181
Avanir Pharmaceuticals, Inc.10$173
Argenx US, Inc.8$172
Amneal Pharmaceuticals LLC10$162
Tanabe Pharma America, Inc.6$151
GE HealthCare8$148
EMD Serono, Inc.5$144
Idorsia Pharmaceuticals US Inc7$136
CSL Behring6$136
Adamas Pharmaceuticals, Inc.7$132
Akcea Therapeutics, Inc.1$121
Corium, LLC7$117
Biohaven Pharmaceuticals, Inc.4$93
Averitas Pharma Inc.1$72
Upsher-smith Laboratories LLC4$71
Zyla Life Sciences, Inc.4$65
Alfasigma USA, Inc.3$61
Avion Pharmaceuticals4$60
Genentech USA, Inc.3$59
Livanova USA, Inc.3$59
Almatica Pharma LLC3$57
C2n Diagnostics, LLC2$56
Insightec,inc2$55
Aprecia Pharmaceuticals, LLC3$50
Inspire Medical Systems, Inc.1$49
Vertical Pharmaceuticals, LLC2$45
Takeda Pharmaceuticals U.S.A., Inc.2$45
Sumitomo Pharma America, Inc.2$42
Shire North American Group Inc2$38
Arbor Pharmaceuticals, Inc.2$37
Catalyst Pharmaceuticals, Inc.1$35
Assertio Therapeutics, Inc.2$31

How this compares

$24,608 in reported general payments places this provider in the 85th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$187,716
Medicare patients
262
Services billed
4,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →